Muscle sympathetic nervous activity in depressed patients before and after treatment with sertraline
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Sympathetic hyperactivity is one of the mechanisms involved in the increased cardiovascular risk associated with depression, and there is evidence that antidepressants decrease sympathetic activity. OBJECTIVES: We tested the following two hypotheses: patients with major depressive disorder with high scores of depressive symptoms (HMDD) have augmented muscle sympathetic nervous system activity (MSNA) at rest and during mental stress compared with patients with major depressive disorder with low scores of depressive symptoms (LMDD) and controls; sertraline decreases MSNA in depressed patients. METHODS: Ten HMDD, nine LMDD and 11 body weight-matched controls were studied. MSNA was directly measured from the peroneal nerve using microneurography for 3 min at rest and 4 min during the Stroop color word test. For the LMDD and HMDD groups, the tests were repeated after treatment with sertraline (103.3 +/- 40 mg). RESULTS: Resting MSNA was significantly higher in the HMDD [29.1 bursts/min (SE 2.9)] compared with LMDD [19.9 (1.6)] and controls [22.2 (2.0)] groups (P = 0.026 and 0.046, respectively). There was a significant positive correlation between resting MSNA and severity of depression. MSNA increased significantly and similarly during stress in all the studied groups. Sertraline significantly decreased resting MSNA in the LMDD group and MSNA during mental stress in LMDD and HMDD groups. Sertraline significantly decreased resting heart rate and heart rate response to mental stress in the HMDD group. CONCLUSION: Moderate-to-severe depression is associated with increased MSNA. Sertraline treatment reduces MSNA at rest and during mental challenge in depressed patients, which may have prognostic implications in this group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485
Training and quality assurance with the structured clinical interview for DSM-iV (SCID-I/P)
Ventura, J., Liberman, R. P., Green, M. F., Shaner, A., & Mintz, J. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00038-9 · Cited by 591
Depression and immune function
Kiecolt-Glaser, J. K., & Glaser, R. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00309-4 · Cited by 571
Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?
Barton, D. A., Dawood, T., Lambert, E. A., Esler, M. D., Haikerwal, D., Brenchley, C., Socratous, F., Kaye, D. M., Schlaich, M. P., Hickie, I., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32829baae7 · Cited by 291
Age-related changes in muscle sympathetic nerve activity in essential hypertension
Yamada, Y., Miyajima, E., Tochikubo, O., Matsukawa, T., & Ishii, M. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.870 · Cited by 220
Heart rate variability in patients with major depression
Yeragani, V. K., Pohl, R., Balon, R., Ramesh, C., Glitz, D., Jung, I., & Sherwood, P. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90104-w · Cited by 206
Enhanced cardiovascular and catecholamine responses in women with depressive symptoms
Light, K. C., Kothandapani, R. V., & Allen, M. T. (1998) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(97)00093-7 · Cited by 189
HPA and Immune Axes in Stress: Involvement of the Serotonergic System
Leonard, B. E. (2006) · Neuroimmunomodulation · doi:10.1159/000104854 · Cited by 169
Captopril and Enalapril Improve Cognition and Depressed Mood in Hypertensive Patients
Braszko, Karwowska-Polecka, Halicka, & Gard (2003) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.2003.14.4.323 · Cited by 89
Abnormal Neurovascular Control during Sympathoexcitation in Obesity
Kuniyoshi, F. H. S., Trombetta, I. C., Batalha, L. T., Rondon, M. U. P. B., Laterza, M. C., Gowdak, M. M. G., Barretto, A. C. P., Halpern, A., Villares, S. M. F., Lima, E. G., et al. (2003) · Obesity Research · doi:10.1038/oby.2003.190 · Cited by 74
Self-citation
Cited by
Meng, L., Chen, D., Yang, Y., Zheng, Y., & Hui, R. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835080b7 · Cited by 526
“[36] found that depression is associated with increased muscle sympathetic nervous system activity, whereas Barton et al.”
BackgroundSchiweck, C., Piette, D., Berckmans, D., Claes, S., & Vrieze, E. (2019) · Psychological Medicine · doi:10.1017/s0033291718001988 · Cited by 290
Heart rate variability alterations in late life depression: A meta-analysis
Brown, L., Karmakar, C., Gray, R., Jindal, R., Lim, T., & Bryant, C. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.071 · Cited by 108
Depression and cardiovascular disease: an update on how course of illness may influence risk
Fiedorowicz, J. G. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0492-6 · Cited by 103
“This finding was replicated in another small study which additionally found that treatment with sertraline reduced muscle sympathetic nerve activity both at rest and in response to mental stress [51].”
ResultRaina, J., El-Messidi, A., Badeghiesh, A., Tulandi, T., Nguyen, T.-V., & Suarthana, E. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.10.058 · Cited by 48
Zhong, Z., Wang, L., Wen, X., Liu, Y., Fan, Y., & Liu, Z. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s141832 · Cited by 46
Mar, P. L., Raj, V., Black, B. K., Biaggioni, I., Shibao, C. A., Paranjape, S. Y., Dupont, W. D., Robertson, D., & Raj, S. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113512911 · Cited by 24
Metadata
- Authors
- Scalco, A. Z., Rondon, M. U., Trombetta, I. C., Laterza, M. C., Azul, J. B., Pullenayegum, E. M., Scalco, M. Z., Kuniyoshi, F. H., Wajngarten, M., Negrão, C. E., & Lotufo-Neto, F.
- Venue
- Journal of Hypertension
- Published
- 2009-12
- Volume
- 27
- Issue
- 12
- Pages
- 2429-2436
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1966317112
- Cited by
- 75
- References
- 10
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.